Medpace Completes Construction on a New Clinical Pharmacology Unit
News Jul 16, 2012
Medpace, Inc. has announced the opening of the new Medpace Clinical Pharmacology Unit (CPU). The CPU unit will operate at 5355 Medpace Way, Cincinnati, OH. The existing facility in Norwood will close at the conclusion of the move. The new Medpace CPU is a 60,000 square foot state-of-the-art facility doubling the size of the previous CPU -- increasing Medpace's ability to conduct multiple studies with a total of 96 beds for overnight stays. The facility houses a pharmacy, processing labs, and a dedicated patient recruitment staff for both the recruitment and screening of study subjects. The new CPU joins the Medpace global headquarters and the Medpace Clinical Research Organization (CRO).
"The new CPU facility is designed to conduct best in class Phase I studies -- doubling our current capacity and investing in cutting edge instrumentation and process," said Dr. August Troendle, President, Medpace. "The vision for a state of the art campus began in 2008 with the construction of the existing CRO and global headquarters building. By the end of 2012, we will see the completion of Medpace Reference Laboratories (MRL) and Medpace Bioanalytical Laboratories (MBL) facility at the new location. The CPU and the labs complete the fully integrated campus."
A form of the hallucinogenic party drug ketamine has cleared one of the final hurdles toward clinical use as an antidepressant. During a meeting at the US Food and Drug Administration (FDA) in Silver Spring, Maryland, an independent advisory panel voted 14-2 in favor of recommending a compound known as esketamine for use in treating depression.READ MORE